US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 28.970
  • +0.990+3.54%
Trading Nov 4 15:40 ET
3.53BMarket Cap-10650P/E (TTM)

Apellis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
110.26%199.69M
284.26%172.33M
425.83%396.59M
545.89%146.38M
400.54%110.4M
481.85%94.97M
211.84%44.85M
13.31%75.42M
-62.41%22.66M
290.37%22.06M
Operating revenue
110.26%199.69M
284.26%172.33M
425.83%396.59M
545.89%146.38M
400.54%110.4M
481.85%94.97M
211.84%44.85M
13.31%75.42M
-62.41%22.66M
290.37%22.06M
Cost of revenue
175.69%23.1M
158.79%20.21M
938.15%58.51M
580.75%19.91M
1,522.74%22.41M
10,118.29%8.38M
526.22%7.81M
8.38%5.64M
-42.09%2.93M
826.85%1.38M
Gross profit
103.93%176.59M
310.71%152.12M
384.45%338.08M
540.72%126.47M
325.58%87.99M
433.19%86.59M
181.99%37.04M
13.73%69.79M
-64.27%19.74M
275.84%20.68M
Operating expense
-0.48%206.03M
0.98%214.21M
28.72%855.2M
14.80%210.98M
29.64%225.07M
25.58%207.03M
49.24%212.12M
11.17%664.4M
27.07%183.79M
30.05%173.61M
Selling and administrative expenses
15.00%128.08M
26.85%129.51M
80.69%500.82M
67.96%141.7M
85.76%145.65M
76.21%111.37M
99.45%102.09M
56.79%277.16M
103.48%84.37M
71.33%78.41M
-General and administrative expense
----
----
80.69%500.82M
67.96%141.7M
85.76%145.65M
----
----
56.79%277.16M
103.48%84.37M
71.33%78.41M
Research and development costs
-18.51%77.95M
-23.02%84.7M
-8.48%354.39M
-30.32%69.28M
-16.58%79.42M
-5.90%95.66M
20.98%110.03M
-7.99%387.24M
-3.64%99.42M
8.52%95.21M
Operating profit
75.55%-29.44M
64.54%-62.09M
13.03%-517.12M
48.48%-84.52M
10.37%-137.08M
18.96%-120.44M
-35.73%-175.08M
-10.88%-594.61M
-83.50%-164.05M
-19.49%-152.94M
Net non-operating interest income expense
-361.17%-6.18M
-71.54%-3.66M
63.53%-8.65M
9.77%-2.85M
54.44%-2.32M
80.92%-1.34M
74.69%-2.14M
-84.92%-23.71M
-6.11%-3.16M
-138.26%-5.09M
Non-operating interest income
-46.95%3.18M
-38.75%3.3M
134.83%20.93M
-0.59%4.55M
77.61%4.99M
319.13%6M
5,403.06%5.39M
2,032.54%8.91M
12,264.86%4.58M
1,850.69%2.81M
Non-operating interest expense
27.49%9.36M
-7.46%6.97M
-9.33%29.58M
-4.34%7.4M
-7.50%7.31M
-13.10%7.34M
-11.82%7.53M
146.40%32.63M
156.39%7.74M
246.32%7.9M
Other net income (expense)
-2,955.56%-1.93M
-80.14%-499K
97.81%-727K
189.02%219K
98.16%-603K
-142.28%-63K
4.15%-277K
83.15%-33.18M
99.55%-246K
49.89%-32.79M
Special income (charges)
---1.95M
----
--0
--0
--0
--0
----
67.30%-32.89M
--0
46.17%-32.89M
-Less:Other special charges
--1.95M
----
----
----
----
----
----
-67.30%32.89M
--0
-46.17%32.89M
Other non- operating income (expenses)
138.10%24K
-80.14%-499K
-152.43%-727K
189.02%219K
-709.09%-603K
-142.28%-63K
4.15%-277K
-121.15%-288K
-6,050.00%-246K
184.62%99K
Income before tax
69.19%-37.54M
62.67%-66.25M
19.19%-526.5M
47.96%-87.15M
26.63%-140M
21.64%-121.84M
-28.88%-177.5M
12.67%-651.5M
-13.47%-167.46M
2.43%-190.82M
Income tax
-41.24%114K
-39.72%170K
218.68%2.13M
196.74%1.42M
-47.76%233K
-60.08%194K
-76.66%282K
90.06%669K
-517.90%-1.47M
446K
Net income
69.14%-37.66M
62.64%-66.42M
18.94%-528.63M
46.64%-88.58M
26.68%-140.24M
21.76%-122.04M
-27.96%-177.78M
12.62%-652.17M
-12.21%-165.99M
2.20%-191.27M
Net income continuous Operations
69.14%-37.66M
62.64%-66.42M
18.94%-528.63M
46.64%-88.58M
26.68%-140.24M
21.76%-122.04M
-27.96%-177.78M
12.62%-652.17M
-12.21%-165.99M
2.20%-191.27M
Minority interest income
Net income attributable to the parent company
69.14%-37.66M
62.64%-66.42M
18.94%-528.63M
46.64%-88.58M
26.68%-140.24M
21.76%-122.04M
-27.96%-177.78M
12.62%-652.17M
-12.21%-165.99M
2.20%-191.27M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
69.14%-37.66M
62.64%-66.42M
18.94%-528.63M
46.64%-88.58M
26.68%-140.24M
21.76%-122.04M
-27.96%-177.78M
12.62%-652.17M
-12.21%-165.99M
2.20%-191.27M
Basic earnings per share
70.59%-0.3
65.38%-0.54
27.64%-4.45
51.33%-0.73
33.14%-1.17
30.14%-1.02
-9.86%-1.56
30.43%-6.15
1.96%-1.5
23.25%-1.75
Diluted earnings per share
70.59%-0.3
65.38%-0.54
27.64%-4.45
51.33%-0.73
33.14%-1.17
30.14%-1.02
-9.86%-1.56
30.43%-6.15
1.96%-1.5
23.25%-1.75
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 110.26%199.69M284.26%172.33M425.83%396.59M545.89%146.38M400.54%110.4M481.85%94.97M211.84%44.85M13.31%75.42M-62.41%22.66M290.37%22.06M
Operating revenue 110.26%199.69M284.26%172.33M425.83%396.59M545.89%146.38M400.54%110.4M481.85%94.97M211.84%44.85M13.31%75.42M-62.41%22.66M290.37%22.06M
Cost of revenue 175.69%23.1M158.79%20.21M938.15%58.51M580.75%19.91M1,522.74%22.41M10,118.29%8.38M526.22%7.81M8.38%5.64M-42.09%2.93M826.85%1.38M
Gross profit 103.93%176.59M310.71%152.12M384.45%338.08M540.72%126.47M325.58%87.99M433.19%86.59M181.99%37.04M13.73%69.79M-64.27%19.74M275.84%20.68M
Operating expense -0.48%206.03M0.98%214.21M28.72%855.2M14.80%210.98M29.64%225.07M25.58%207.03M49.24%212.12M11.17%664.4M27.07%183.79M30.05%173.61M
Selling and administrative expenses 15.00%128.08M26.85%129.51M80.69%500.82M67.96%141.7M85.76%145.65M76.21%111.37M99.45%102.09M56.79%277.16M103.48%84.37M71.33%78.41M
-General and administrative expense --------80.69%500.82M67.96%141.7M85.76%145.65M--------56.79%277.16M103.48%84.37M71.33%78.41M
Research and development costs -18.51%77.95M-23.02%84.7M-8.48%354.39M-30.32%69.28M-16.58%79.42M-5.90%95.66M20.98%110.03M-7.99%387.24M-3.64%99.42M8.52%95.21M
Operating profit 75.55%-29.44M64.54%-62.09M13.03%-517.12M48.48%-84.52M10.37%-137.08M18.96%-120.44M-35.73%-175.08M-10.88%-594.61M-83.50%-164.05M-19.49%-152.94M
Net non-operating interest income expense -361.17%-6.18M-71.54%-3.66M63.53%-8.65M9.77%-2.85M54.44%-2.32M80.92%-1.34M74.69%-2.14M-84.92%-23.71M-6.11%-3.16M-138.26%-5.09M
Non-operating interest income -46.95%3.18M-38.75%3.3M134.83%20.93M-0.59%4.55M77.61%4.99M319.13%6M5,403.06%5.39M2,032.54%8.91M12,264.86%4.58M1,850.69%2.81M
Non-operating interest expense 27.49%9.36M-7.46%6.97M-9.33%29.58M-4.34%7.4M-7.50%7.31M-13.10%7.34M-11.82%7.53M146.40%32.63M156.39%7.74M246.32%7.9M
Other net income (expense) -2,955.56%-1.93M-80.14%-499K97.81%-727K189.02%219K98.16%-603K-142.28%-63K4.15%-277K83.15%-33.18M99.55%-246K49.89%-32.79M
Special income (charges) ---1.95M------0--0--0--0----67.30%-32.89M--046.17%-32.89M
-Less:Other special charges --1.95M-------------------------67.30%32.89M--0-46.17%32.89M
Other non- operating income (expenses) 138.10%24K-80.14%-499K-152.43%-727K189.02%219K-709.09%-603K-142.28%-63K4.15%-277K-121.15%-288K-6,050.00%-246K184.62%99K
Income before tax 69.19%-37.54M62.67%-66.25M19.19%-526.5M47.96%-87.15M26.63%-140M21.64%-121.84M-28.88%-177.5M12.67%-651.5M-13.47%-167.46M2.43%-190.82M
Income tax -41.24%114K-39.72%170K218.68%2.13M196.74%1.42M-47.76%233K-60.08%194K-76.66%282K90.06%669K-517.90%-1.47M446K
Net income 69.14%-37.66M62.64%-66.42M18.94%-528.63M46.64%-88.58M26.68%-140.24M21.76%-122.04M-27.96%-177.78M12.62%-652.17M-12.21%-165.99M2.20%-191.27M
Net income continuous Operations 69.14%-37.66M62.64%-66.42M18.94%-528.63M46.64%-88.58M26.68%-140.24M21.76%-122.04M-27.96%-177.78M12.62%-652.17M-12.21%-165.99M2.20%-191.27M
Minority interest income
Net income attributable to the parent company 69.14%-37.66M62.64%-66.42M18.94%-528.63M46.64%-88.58M26.68%-140.24M21.76%-122.04M-27.96%-177.78M12.62%-652.17M-12.21%-165.99M2.20%-191.27M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 69.14%-37.66M62.64%-66.42M18.94%-528.63M46.64%-88.58M26.68%-140.24M21.76%-122.04M-27.96%-177.78M12.62%-652.17M-12.21%-165.99M2.20%-191.27M
Basic earnings per share 70.59%-0.365.38%-0.5427.64%-4.4551.33%-0.7333.14%-1.1730.14%-1.02-9.86%-1.5630.43%-6.151.96%-1.523.25%-1.75
Diluted earnings per share 70.59%-0.365.38%-0.5427.64%-4.4551.33%-0.7333.14%-1.1730.14%-1.02-9.86%-1.5630.43%-6.151.96%-1.523.25%-1.75
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Gene Editing
Gene Editing
Intraday+0.44%